Efficient production of recombinant proteins in suspension CHO cells culture using the Tol2 transposon system coupled with cycloheximide resistance selection

Author:

Yamaguchi Keina1,Ogawa Risa2,Tsukahara Masayoshi2,Kawakami Koichi1

Affiliation:

1. National Institute of Genetics

2. Kyowa Kirin Co., Ltd

Abstract

Abstract DNA recombination techniques in mammalian cells has been applied to the production of therapeutic proteins for several decades. To be used for commercial production, established cell lines should stably express target proteins with high productivity and acceptable quality for human use. In the conventional transfection method, the screening process is laborious and time-consuming since superior cell lines had to be selected from an enormous number of transfected cell pools and clonal cell lines with a wide variety of transgene insertion locations. In this study, we demonstrated that the combination of a Tol2 transposon system and cell selection by cycloheximide resistance is an efficient method to express therapeutic proteins, such as human antibody in suspension culture of Chinese hamster ovary (CHO) cells. The resulting stable cell lines showed constant productivity and cell growth over a long enough cultivation periods for recombinant protein production. We anticipate that this approach will prove widely applicable to protein production in research and development of pharmaceutical products.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Production of recombinant protein therapeutics in cultivated mammalian cells;Wurn FM;Nat. Biotechnol.,2004

2. Identification of transgene integration loci of different highly expressing recombinant CHO cell lines by FISH;Lattenmayer C;Cytotechnology,2006

3. Amplification and loss of dihydrofolate reductase genes in a Chinese hamster ovary cell line;Kaufman RJ;Mol. Cell Biol.,1981

4. Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene;Kaufman RJ;J. Mol. Biol.,1982

5. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cell;Kwaks TH;Trends Biotechnol.,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3